XDH and idiopathic dilated cardiomyopathy: Cappola et al. have demonstrated that short-term administration of allopurinol, a selective XO inhibitor, is able to improve myocardial efficiency in patients with idiopathic dilated cardiomyopathy, suggesting that XO may contribute to mechanoenergetic uncoupling in human heart failure.